|
Daunorubicin Hydrochloride Clinical Trials
7 actively recruiting trials across 2 locations
▼ -1 trial since May 2026
Also known as: Cerubidin, Cerubidine, Cloridrato de Daunorubicina, Daunoblastin, Daunoblastina +10 more
Pipeline
Phase 2: 4Phase 3: 3
Top Sponsors
- National Cancer Institute (NCI)3
- Children's Oncology Group2
- City of Hope Medical Center1
- Alliance for Clinical Trials in Oncology1
Indications
- Cancer7
- Acute Myeloid Leukemia4
- Acute Myeloid Leukemia, Myelodysplasia-Related2
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm2
- B Acute Lymphoblastic Leukemia2
Birmingham, Alabama6 trials
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Hospital of Alabama
Phase 3
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
University of Alabama at Birmingham Cancer Center
Phase 2
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
University of Alabama at Birmingham Cancer Center
Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Children's Hospital of Alabama
Phase 3
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
University of Alabama at Birmingham Cancer Center
Phase 2
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
University of Alabama at Birmingham Cancer Center
Phase 2
Phoenix, Arizona1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.